Kristin Wynholds
CIK 1889329 · Chief Product Officer · last filed 2023-12-20
Kristin Wynholds is a Chief Product Officer who has filed 4 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for BTTX, was dated Dec 20, 2023.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Better Therapeutics, Inc. (BTTX) Delisted | Chief Product Officer | 225,631 | $0.04 | $10.1K | $0 | 4 | 2023-12-20 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-20 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | +25,362 | $0 | EDGAR |
| 2023-04-21 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | +101,450 | $0 | EDGAR |
| 2022-12-02 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | +8,804 | $12.4K | EDGAR |
| 2022-04-04 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | — | $0 | EDGAR |